Diagnostic Accuracy of Screening Arterial Spin-Labeling MRI Using Hadamard Encoding for the Detection of Reduced CBF in Adult Patients with Ischemic Moyamoya Disease

References

1. 1.↵
   Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis. Neurol Med Chir (Tokyo) 2012;52:245–66 doi:10.2176/nmc.52.245 pmid:22870528

   CrossRefPubMed
2. 2.↵
   2. Suzuki J,
   3. Takaku A

   . Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99 doi:10.1001/archneur.1969.00480090076012 pmid:5775283

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Fujimura M,
   3. Tominaga T

   . Current status of revascularization surgery for moyamoya disease: special consideration for its ‘internal carotid-external carotid (IC-EC) conversion’ as the physiological reorganization system. Tohoku J Exp Med 2015;236:45–53 doi:10.1620/tjem.236.45 pmid:25971859

   CrossRefPubMed
4. 4.↵
   2. Fujimura M,
   3. Shimizu H,
   4. Mugikura S, et al

   . Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 2009;71:223–27 doi:10.1016/j.surneu.2007.07.077 pmid:18291489

   CrossRefPubMed
5. 5.↵
   2. Fushimi Y,
   3. Okada T,
   4. Takagi Y, et al

   . Voxel based analysis of surgical revascularization for moyamoya disease: pre- and postoperative SPECT studies. PLoS One 2016;11:e0148925 doi:10.1371/journal.pone.0148925 pmid:26867219

   CrossRefPubMed
6. 6.↵
   2. Guzman R,
   3. Lee M,
   4. Achrol A, et al

   . Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg 2009;111:927–35 doi:10.3171/2009.4.JNS081649 pmid:19463046

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Miyoshi K,
   3. Chida K,
   4. Kobayashi M, et al

   . Two-year clinical, cerebral hemodynamic and cognitive outcomes of adult patients undergoing medication alone for symptomatically ischemic moyamoya disease without cerebral misery perfusion: a prospective cohort study. Neurosurgery 2018;84:1233–41 doi:10.1093/neuros/nyy234 pmid:29850833

   CrossRefPubMed
8. 8.↵
   2. Nam KW,
   3. Cho WS,
   4. Kwon HM, et al

   . Ivy sign predicts ischemic stroke recurrence in adult moyamoya patients without revascularization surgery. Cerebrovasc Dis 2019;47:223–30 doi:10.1159/000500610 pmid:31212276

   CrossRefPubMed
9. 9.↵
   2. Williams DS,
   3. Detre JA,
   4. Leigh JS, et al

   . Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992;89:212–16 doi:10.1073/pnas.89.1.212 pmid:1729691

   Abstract/FREE Full Text
10. 10.↵
    2. Alsop DC,
    3. Detre JA

    . Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236–49 doi:10.1097/00004647-199611000-00019 pmid:8898697

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Detre JA,
    3. Samuels OB,
    4. Alsop DC, et al

    . Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging 1999;10:870–75 doi:10.1002/(SICI)1522-2586(199911)10:5<870::AID-JMRI36>3.0.CO;2-D pmid:10548801

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Goetti R,
    3. Warnock G,
    4. Kuhn FP, et al

    . Quantitative cerebral perfusion imaging in children and young adults with moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET. AJNR Am J Neuroradiol 2014;35:1022–28 doi:10.3174/ajnr.A3799 pmid:24335546

    Abstract/FREE Full Text
13. 13.↵
    2. Yun TJ,
    3. Sohn CH,
    4. Han MH, et al

    . Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease. Invest Radiol 2013;48:795–802 doi:10.1097/RLI.0b013e3182981137 pmid:23764569

    CrossRefPubMed
14. 14.↵
    2. Noguchi T,
    3. Kawashima M,
    4. Irie H, et al

    . Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging. Eur J Radiol 2011;80:e557–62 doi:10.1016/j.ejrad.2011.01.016 pmid:21315533

    CrossRefPubMed
15. 15.↵
    2. Hara S,
    3. Tanaka Y,
    4. Ueda Y, et al

    . Noninvasive evaluation of CBF and perfusion delay of moyamoya disease using arterial spin-labeling MRI with multiple postlabeling delays: comparison with 15O-gas PET and DSC-MRI. AJNR Am J Neuroradiol 2017;38:696–702 doi:10.1002/mrm.25197 pmid:24715426

    Abstract/FREE Full Text
16. 16.↵
    2. Gunther M

    . Highly efficient accelerated acquisition of perfusion inflow series by cycled arterial spin labeling. In: Proceedings of the 15th Annual Meeting of International Society of Magnetic Resonance in Medicine and the European Society for Magnetic Resonance in Medicine and Biology, Berlin, Germany; May 19–25, 2007
17. 17.↵
    2. Wells JA,
    3. Lythgoe MF,
    4. Gadian DG, et al

    . In vivo Hadamard-encoded continuous arterial spin-labeling (H-CASL). Magn Reson Med 2010;63:1111–18 doi:10.1002/mrm.22266 pmid:20373414

    CrossRefPubMed
18. 18.↵
    2. Fan AP,
    3. Khalighi MM,
    4. Guo J, et al

    . Identifying hypoperfusion in moyamoya disease with arterial spin labeling and an [15O]-water positron emission tomography/magnetic resonance imaging normative database. Stroke 2019;50:373–80 doi:10.1161/STROKEAHA.118.023426 pmid:30636572

    CrossRefPubMed
19. 19.↵
    2. Wang R,
    3. Yu S,
    4. Alger JR, et al

    . Multi-delay arterial spin-labeling perfusion MRI in moyamoya disease: comparison with CT perfusion imaging. Eur Radiol 2014;24:1135–44 doi:10.1007/s00330-014-3098-9 pmid:24557051

    CrossRefPubMed
20. 20.↵
    2. Guo J,
    3. Holdsworth SJ,
    4. Fan AP, et al

    . Comparing accuracy and reproducibility of sequential and Hadamard-encoded multidelay pseudocontinuous arterial spin-labeling for measuring cerebral blood flow and arterial transit time in healthy subjects: a simulation and in vivo study. J Magn Reson Imaging 2018;47:1119–32 doi:10.1002/jmri.25834 pmid:28792653

    CrossRefPubMed
21. 21.↵
    2. Chang LT

    . A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638–43 doi:10.1109/TNS.1978.4329385

    CrossRefWeb of Science
22. 22.↵
    2. Setta K,
    3. Kojima D,
    4. Shimada Y, et al

    . Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease. Ann Nucl Med 2018;32:611–19 doi:10.1007/s12149-018-1283-7 pmid:30030783

    CrossRefPubMed
23. 23.↵
    2. Nishimiya M,
    3. Matsuda H,
    4. Imabayashi E, et al

    . Comparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT and MRI at the early stage of Alzheimer’s disease. Ann Nucl Med 2008;22:921–27 doi:10.1007/s12149-008-0211-7 pmid:19142712

    CrossRefPubMed
24. 24.↵
    2. Takeuchi R,
    3. Matsuda H,
    4. Yoshioka K, et al

    . Cerebral blood flow SPET in transient global amnesia with automated ROI analysis by 3DSRT. Eur J Nucl Med Mol Imaging 2004;31:578–89 doi:10.1007/s00259-003-1406-8 pmid:14722677

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Soonawala D,
    3. Amin T,
    4. Ebmeier KP, et al

    . Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer’s disease: normalizing to cerebellar tracer uptake. Neuroimage 2002;17:1193–1202 doi:10.1006/nimg.2002.1259 pmid:12414259

    CrossRefPubMed
26. 26.↵
    2. Ohnishi T,
    3. Yano T,
    4. Nakano S, et al

    . Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease. J Nuc Med 1997;38:1463–67 pmid:9293809

    Abstract/FREE Full Text
27. 27.↵
    2. Alsop DC,
    3. Detre JA,
    4. Golay X, et al

    . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM Perfusion Study Group and the European Consortium for ASL in dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

    CrossRefPubMed